Peptide therapeutics for CNS indications

Biochemical Pharmacology

Volumn 83, Issue 5, 2012, Pages 559-566

  McGonigle, Paul ^a  

^a PSYCHOGENICS INC   (United States)

Author keywords

Amylin; CNS indications; Oxytocin; Peptide therapeutics; Peptides

Indexed keywords

AMYLIN; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; CLOZAPINE; LIPOSOME; MACROGOL; NEUROLEPTIC AGENT; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROTENSIN; NEUROTENSIN RECEPTOR; OCTREOTIDE; OXYTOCIN; OXYTOCIN RECEPTOR; PEGINESATIDE; PEGINTERFERON ALPHA2B; PENTAGASTRIN; PEPTIDE; POLYSIALIC ACID; PRAMLINTIDE; ROMIPLOSTIM; SEROTONIN UPTAKE INHIBITOR; TETRAGASTRIN;

AGITATION; AMINO ACID SEQUENCE; ANXIETY DISORDER; AUTISM; BLOOD BRAIN BARRIER; CONFUSION; COST; DEPRESSION; DIABETES MELLITUS; DROWSINESS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ERUPTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDICATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; ENDOCYTOSIS; EXOCYTOSIS; HEADACHE; HEART BEAT; HUMAN; INSOMNIA; MEMBRANE PERMEABILITY; METABOLIC SYNDROME X; MUSCLE RIGIDITY; MUSCLE SPASM; NAUSEA; NIGHTMARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ENGINEERING; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SHELF LIFE; SIDE EFFECT; TRANQUILIZING ACTIVITY; TREMOR; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 84856103580     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.10.014     Document Type: Note

References (75)

1. R. Caceda, B. Kinkead, and C.B. Nemeroff Neurotensin: role in psychiatric and neurological diseases Peptides 27 2006 2385 2404 (Pubitemid 44402784)
2. G.R. Uhl Distribution of neurotensin and its receptor in the central nervous system Ann N Y Acad Sci 400 1982 132 149 (Pubitemid 13138570)
3. A. Fassio, G. Evans, R. Grisshammer, J.P. Bolam, M. Mimmack, and P.C. Emson Distribution of the neurotensin receptor in the rat CNS studied using an amino-terminal directed antibody Neuropharmacology 39 2000 1430 1442 (Pubitemid 30249205)
4. E.B. Binder, B. Kinkead, M.J. Owens, and C.B. Nemeroff The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs Biol Psychiatry 50 2001 856 872 (Pubitemid 34020699)
5. N.A. Breslin, R.L. Suddath, G. Bissette, C.B. Nemeroff, P. Lowrimore, and D.R. Weinberger CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates Schizophr Res 12 1994 35 41 (Pubitemid 24135493)
6. T. Hokfelt, P. Morino, V. Verge, M.N. Castel, C. Broberger, and X. Zhang CCK in cerebral cortex and at the spinal level Ann N Y Acad Sci 15 1994 7 163
7. N. Lindefors, A. Lindén, S. Brené, G. Sedvall, and H. Persson CCK peptides and mRNA in the human brain Prog Neurobiol 40 1993 671 690 (Pubitemid 23094670)
8. M. Savasta, E. Ruberte, J.M. Palacios, and G. Mengod The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridization Neuroscience 29 1989 363 369 (Pubitemid 19113427)
9. J.N. Crawley, and R.L. Corwin Biological actions of cholecystokinin Peptides 15 1994 731 755 (Pubitemid 24221851)
10. S.L. Cohen, M. Knight, C.A. Tamminga, and T.N. Chase Cholecystokinin- octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy Eur J Pharmacol 83 1982 213 222 (Pubitemid 12001163)
11. G. Zetler Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methyphenidate and picrotoxin Eur J Pharmacol 94 1983 261 270 (Pubitemid 14245526)
12. L.H. Schneider, J.E. Alpert, and S.D. Iversen CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors Peptides 4 1983 749 753 (Pubitemid 14223726)
13. F.J. Vaccarino, and J. Rankin Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function Behav Neurosci 103 1989 831 836 (Pubitemid 19218415)
14. J.N. Crawley Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway J Neurosci 12 1992 3380 3391
15. D. Feifel, T. Reza, and S. Robeck Antipsychotic potential of CCK-based treatments Neuropsychopharmacology 20 1999 141 149
16. H. Tachikawa, S. Harada, Y. Kawanishi, T. Okubo, and T. Suzuki Linkded polymorphisms (-33G > T and -286A > G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia Psychiatry Res 103 2001 147 155 (Pubitemid 32817076)
17. N.P.V. Nair, S. Lal, and D.M. Bloom Cholecystokinin peptides, dopamine and schizophrenia - a review Prog Neuropsychopharmacol Biol Psychiatry 9 1985 515 524 (Pubitemid 16148253)
18. S.A. Montgomery, and M.C. Green The use of cholecystokinin in schizophrenia Psychol Med 18 1988 593 603
19. F. Loup, E. Tribollet, M. Dubois-Dauphin, and J.J. Dreifuss Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study Brain Res 555 1991 220 232
20. C.A. Pedersen, and M.L. Boccia Oxytocin antagonism alters rat dams' oral grooming and upright posturing over pups Physiol Behav 80 2003 233 241 (Pubitemid 37456759)
21. L.J. Young, and Z. Wang The neurobiology of pair bonding Nat Neurosci 7 2004 1048 1054 (Pubitemid 41184443)
22. L.E. Shapiro, and T.R. Insel Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles Ann NY Acad Sci 652 1992 448 451
23. H.E. Ross, S.M. Freeman, L.L. Spiegel, X. Ren, E.F. Terwilliger, and L.J. Young Variation in oxytocin receptor density in the nucleus accumbens has differential effects on affiliative behaviors in monogamous and polygamous voles J Neurosci 29 2009 1312 1318
24. A. Benelli, A. Bertolini, R. Poggioli, B. Menozzi, R. Basaglia, and R. Arletti Polymodal dose-response curve for oxytocin in the social recognition test Neuropeptides 28 1995 251 255
25. J.N. Ferguson, J.M. Aldag, T.R. Insel, and L.J. Young Oxytocin in the medial amygdala is essential for social recognition in the mouse J Neurosci 21 2001 8278 8285 (Pubitemid 32952782)
26. Y. Takayanagi, M. Yoshida, I.F. Bielsky, H.E. Ross, M. Kawamata, and T. Onaka Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice Proc Natl Acad Sci USA 102 2005 16096 16101 (Pubitemid 41552873)
27. U. Rimmele, K. Hediger, M. Heinrichs, and P. Klaver Oxytocin makes a face in memory familiar J Neurosci 29 2009 38 42
28. A. Stachowiak, C. Macchi, G.G. Nussdorfer, and L.K. Malendowicz Effect of oxytocin on the function and morphology of the rat adrenal cortex: in vitro and in vivo investigations Res Exp Med (Berl.) 195 1995 265 274
29. J.J. Legros Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones? Psychoneuroendocrinology 26 2001 6499 6555
30. R.H. Ring, J.E. Malberg, L. Potestio, J. Ping, S. Boikess, and B. Luo Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications Psychopharmacology 185 2006 218 225 (Pubitemid 43363618)
31. R.H. Ring, L.E. Schechter, S.K. Leonard, J.M. Dwyer, B.J. Platt, and R. Graf Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist Neuropharmacology 58 2010 69 77
32. P. Kirsch, C. Esslinger, Q. Chen, D. Mier, S. Lis, and S. Siddhanti Oxytocin modulates neural circuitry for social cognition and fear in humans J Neurosci 25 2005 11489 11493 (Pubitemid 43083720)
33. M. Heinrichs, T. Baumgartner, C. Kirschbaum, and U. Ehlert Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress Biol Psychiatry 54 2003 1389 1398 (Pubitemid 37522163)
34. G. Scantamburlo, M. Hansenne, S. Fuchs, W. Pitchot, P. Marechal, and C. Pequex Plasma oxytocin level and anxiety in patients with major depression Psychoneuroendocrinology 32 2007 407 410 (Pubitemid 46617779)
35. K. Uvnas-Moberg, P. Alster, and T.H. Svensson Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats Psychopharmacology 109 1992 473 476
36. D. Feifel, and T. Reza Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating Psychopharmacology 141 1999 93 98 (Pubitemid 29193300)
37. D. Feifel, K. Macdonald, A. Nguyen, P. Cobb, H. Warlan, and B. Galangue Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients Biol Psychiatry 68 2010 678 680
38. C. Modahl, L. Green, D. Fein, M. Morris, L. Waterhouse, and C. Feinstein Plasma oxytocin levels in autistic children Biol Psychiatry 43 1998 270 277 (Pubitemid 28085673)
39. C.M. Yrigollen, S.S. Han, A. Kochetkova, T. Babitz, J.T. Chang, and F.R. Volkmar Genes controlling affiliative behavior as candidate genes for autism Biol Psychiatry 63 2008 911 916
40. E. Hollander, J. Bartz, W. Chaplin, A. Phillips, J. Sumner, and L. Soorya Oxytocin increases retention of social cognition in autism Biol Psychiatry 61 2007 498 503 (Pubitemid 46185336)
41. E. Hollander, S. Novotny, M. Hanratty, R. Yaffe, C.M. DeCaria, and B.R. Aronowitz Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders Neuropsychopharmacology 28 2003 193 198
42. B.M. Chronwall, D.A. Dimaggio, V.J. Massari, V.M. Pickel, D.A. Ruggerio, and T.L. O'Donohue The anatomy of neuropeptide Y-containing neurons in the rat brain Neurscience 115 1985 9 1181
43. A. Kask, J. Harro, S. von Horsten, J.P. Redrobe, Y. Dumont, and R. Quirion The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y Neurosci Biobehav 26 2002 259 283 (Pubitemid 34555409)
44. M. Heilig, and A. Thorsell Brain neuropeptide Y (NPY) in stress and alchohol dependence Rev Neurosci 13 2002 85 94
45. M. Heilig, B. Soderpalm, J.A. Engel, and E. Widerlov Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacology 98 1989 524 529 (Pubitemid 19193902)
46. R.M. Karlsson, A. Holmes, M. Heilig, and J.N. Crawley Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice Pharmacol Biochem Behav 80 2005 427 436 (Pubitemid 40299344)
47. T.J. Sajdyk, M.G. Vandergriff, and D.R. Gehlert Amygdalar neuropeptide Y Y-1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test Eur J Pharmacol 368 1999 143 147 (Pubitemid 29117135)
48. J.P. Redrobe, Y. Dumont, A. Fournier, and R. Quirion The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test Neuropsychopharmacology 26 2002 615 624 (Pubitemid 34260980)
49. S.N. Goyal, M.A. Upadhya, D.M. Kokare, S.M. Bhisikar, and N.K. Subhedar Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors Brain Res 1266 2009 45 53
50. H. Husum, J.D. Mikkelsen, S. Hogg, A.A. Mathé, and A. Mørk Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram Neuropharmacology 39 2000 1463 1473 (Pubitemid 30249208)
51. G. Nikisch, H. Agren, C.B. Eap, A. Czernik, P. Baumann, and A.A. Mathe Neuropeptide Y and corticotrophin-releasing hormone in CSF mark response to antidepressive treatment with citalopram Int J Neuropsychopharmacol 8 2005 403 410 (Pubitemid 41002494)
52. G. Nikisch, and A.A. Mathe CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy Eur Psychiatry 23 2008 356 359
53. J.D. Roth, H. Maier, S. Chen, and B.L. Roland Implications of amylin receptor agonism Arch Neurol 66 2009 306 310
54. T.A. Lutz The role of amylin in the control of energy homeostasis Am J Physiol Regul Integr Comp Physiol 298 2010 R1475 R1484
55. M. Werli, and A. Bernkop-Schnurch Strategies to improve plasma half-life time of peptide and protein drugs Amino Acids 30 2006 351 367 (Pubitemid 43886897)
56. B.D. Green, M.H. Mooney, V.A. Gault, N. Irwin, C.J. Bailey, and P.B.G. Harriott N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity J Endocrinol 180 2004 379 388 (Pubitemid 38443390)
57. A.I. Salhanick, K.B. Clairmont, T.M. Buckholz, C.M. Pellegrino, S. Ha, and K.J. Lumb Contribution of site-specific PEGylation to the dipeptidyl peptidase IV stability of glucose-dependent insulinotropic polypeptide Bioorg Med Chem Lett 15 2005 4114 4117 (Pubitemid 41132672)
58. M. Marastoni, S. Salvadori, V. Scaranari, S. Spisani, E. Reali, and S. Traniello Synthesis and activity of new linear and cyclic peptide T derivatives Arzneimittelforschung 44 1994 1073 1076
59. I.C. Macdougall, J. Rossert, N. Casadevall, R.B. Stead, A.M. Duliege, and M. Froissart A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia N Engl J Med 361 2009 1848 1855
60. D.J. Kuter, J.B. Bussel, R.M. Lyons, V. Pullarkat, T.B. Gernsheimer, and F.M. Senecal Efficacy of romiplostim in patients with chronic immunethrombocytopenic purpura: a double blind randomized controlled trial Lancet 371 2008 362 364
61. I.S. Kim, H.G. Choi, H.S. Choi, B.K. Kim, and C.K. Kim Prolonged systemic delivery of streptokinase using liposome Arch Pharm Res 21 1998 248 252
62. N.V. Katre, J. Asherman, H. Schaefer, and M. Hora Multivesicular liposome (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I) J Pharm Sci 87 1998 1341 1346
63. R. Willis, and Lipid Foams Lipid foams: formulation development and characterization of depointerferon alpha Proceedings of the Fine Particle Society Meeting in San Diego CA, December 2006
64. K.W. Burton, M. Shameem, B.C. Thanoo, and P.P. DeLuca Extended release peptide delivery systems through the use of PLGA microsphere combinations J Biomater Sci Polym Ed 11 2000 715 729
65. M.R. Prausnitz, J.A. Mikszta, M. Cormier, and A.K. Andrianov Microneedle-based vaccines Curr Top Microbiol Immunol 333 2009 369 393
66. W.M. Pardridge Blood-brain barrier delivery Drug Discov Today 12 2007 54 61 (Pubitemid 46014479)
67. H.J. Lee, B. Engelhardt, J. Lesley, U. Bickel, and W.M. Pardridge Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse J Pharmacol Exp Ther 292 2000 1048 1052 (Pubitemid 30136600)
68. W.M. Pardridge, Y.S. Kang, J.L. Buciak, and J. Yang Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate Pharm Res 12 1995 807 816
69. D. Wu, and W.M. Pardridge Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system J Pharmacol Exp Ther 279 1996 77 83 (Pubitemid 27166896)
70. D. Wu, and W.M. Pardridge Neuroprotection with noninvasive neurotrophin delivery to the brain Proc Natl Acad Sci USA 96 1999 254 259 (Pubitemid 29036086)
71. A. Kurihara, and W.M. Pardridge Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier Cancer Res 59 1999 6159 6163 (Pubitemid 30035637)
72. R.J. Boado, Y. Zhang, and W.M. Pardridge Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier Biotechnol Bioeng 97 2007 1376 1386 (Pubitemid 47204016)
73. Y. Y. Zhang, Y. Schlachetzki, and W.M. Pardridge Global non-viral gene transfer to the primate brain following intravenous administration Mol Ther 7 2003 11 18 (Pubitemid 36305354)
74. N. Shi, Y. Zhang, C. Zhu, R.J. Boado, and W.M. Pardridge Brain-specific expression of an exogenous gene after i.v. administration Proc Natl Acad Sci USA 98 2001 12754 12759 (Pubitemid 33026054)
75. M. Demeule, J.C. Currie, Y. Bertrand, C. Che, T. Nguyen, and A. Regina Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2 J Neurochem 106 2008 1534 1544